Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful genotype-tailored treatment with small-dose efavirenz.

× No keyword cloud information.

6 in total

1. Modest but variable effect of rifampin on steady-state plasma pharmacokinetics of efavirenz in healthy African-American and Caucasian volunteers.

Authors: Awewura Kwara; Karen T Tashima; Julie B Dumond; Pamela Poethke; Jaclyn Kurpewski; Angela D M Kashuba; Michael H Court; David J Greenblatt
Journal: Antimicrob Agents Chemother Date: 2011-04-25 Impact factor: 5.191

Review 2. Pharmacogenomics of antimicrobial agents.

Authors: Ar Kar Aung; David W Haas; Todd Hulgan; Elizabeth J Phillips
Journal: Pharmacogenomics Date: 2014 Impact factor: 2.533

3. Influence of CYP2B6 516G>T polymorphism and interoccasion variability (IOV) on the population pharmacokinetics of efavirenz in HIV-infected South African children.

Authors: M Viljoen; M O Karlsson; T M Meyers; H Gous; C Dandara; M Rheeders
Journal: Eur J Clin Pharmacol Date: 2011-11-06 Impact factor: 2.953

4. CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients.

Authors: Awewura Kwara; Margaret Lartey; Kwamena W C Sagoe; Ernest Kenu; Michael H Court
Journal: AIDS Date: 2009-10-23 Impact factor: 4.177

5. Prospective plasma efavirenz concentration assessment in Chinese HIV-infected adults enrolled in a large multicentre study.

Authors: F Guo; X Cheng; E Hsieh; X Du; Q Fu; W Peng; Y Li; X Song; J-P Routy; T Li
Journal: HIV Med Date: 2018-05-15 Impact factor: 3.180

6. Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance.

Authors: Ulrich M Zanger; Kathrin Klein
Journal: Front Genet Date: 2013-03-05 Impact factor: 4.599

6 in total